Epicatechin gallate
| Names | |
|---|---|
| IUPAC name (2R,3R)-3′,4′,5,7-Tetrahydroxyflavan-3-yl 3,4,5-trihydroxybenzoate | |
| Systematic IUPAC name (2R,3R)-2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate | |
| Other names | |
| Identifiers | |
| 3D model (JSmol) | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.116.252 | 
| KEGG | |
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| 
 | |
| 
 | |
| Properties | |
| C22H18O10 | |
| Molar mass | 442.37 g/mol | 
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Epicatechin gallate (ECG, (−)-epicatechin-3-gallate) is a flavan-3-ol, a type of flavonoid, primarily found in green tea (Camellia sinensis), with smaller amounts in cocoa, grapes, and other plants. It is also reported in buckwheat and in grape.
As a polyphenolic catechin, ECG is formed by the esterification of epicatechin with gallic acid, contributing to antioxidant, antimicrobial, and potential anticancer properties. ECG is studied for its ability to reverse methicillin resistance in Staphylococcus aureus and inhibit inflammatory pathways, but its clinical use is limited by poor bioavailability and thermal instability in boiling water. Recent research highlights its potential in modulating SARS-CoV-2-related inflammation and bacterial virulence factors.
Epicatechin, as well as many other flavonoids, has been found to act as a nonselective antagonist of the opioid receptors, albeit with somewhat low affinity.